These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 8620482

  • 21. Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis.
    Lubet RA, Boring D, Steele VE, Ruppert JM, Juliana MM, Grubbs CJ.
    Cancer Prev Res (Phila); 2009 Feb; 2(2):161-7. PubMed ID: 19196723
    [Abstract] [Full Text] [Related]

  • 22. A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis.
    Suh N, Wang Y, Williams CR, Risingsong R, Gilmer T, Willson TM, Sporn MB.
    Cancer Res; 1999 Nov 15; 59(22):5671-3. PubMed ID: 10582681
    [Abstract] [Full Text] [Related]

  • 23. 1 alpha,25-Dihydroxy-16-ene-23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat.
    Anzano MA, Smith JM, Uskoković MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL.
    Cancer Res; 1994 Apr 01; 54(7):1653-6. PubMed ID: 8137276
    [Abstract] [Full Text] [Related]

  • 24. Mechanisms by which energy restriction inhibits rat mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in mammary carcinomas.
    Zhu Z, Jiang W, Thompson HJ.
    Carcinogenesis; 2003 Jul 01; 24(7):1225-31. PubMed ID: 12807724
    [Abstract] [Full Text] [Related]

  • 25. Chemoprevention by dehydroepiandrosterone and indomethacin in a rat multiorgan carcinogenesis model.
    Shibata M, Hasegawa R, Imaida K, Hagiwara A, Ogawa K, Hirose M, Ito N, Shirai T.
    Cancer Res; 1995 Nov 01; 55(21):4870-4. PubMed ID: 7585522
    [Abstract] [Full Text] [Related]

  • 26. The impact of fish oil on the chemopreventive efficacy of tamoxifen against development of N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
    Manni A, Xu H, Washington S, Aliaga C, Cooper T, Richie JP, Bruggeman R, Prokopczyk B, Calcagnotto A, Trushin N, Mauger D, Verderame MF, El-Bayoumy K.
    Cancer Prev Res (Phila); 2010 Mar 01; 3(3):322-30. PubMed ID: 20179301
    [Abstract] [Full Text] [Related]

  • 27. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity.
    Lemieux C, Picard F, Labrie F, Richard D, Deshaies Y.
    Obes Res; 2003 Mar 01; 11(3):477-90. PubMed ID: 12634448
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of Targretin on methylnitrosourea-induced mammary cancers: prevention and therapy dose-response curves and effects on proliferation and apoptosis.
    Lubet RA, Christov K, Nunez NP, Hursting SD, Steele VE, Juliana MM, Eto I, Grubbs CJ.
    Carcinogenesis; 2005 Feb 01; 26(2):441-8. PubMed ID: 15591091
    [Abstract] [Full Text] [Related]

  • 29. Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
    Abou-Issa HM, Alshafie GA, Seibert K, Koki AT, Masferrer JL, Harris RE.
    Anticancer Res; 2001 Feb 01; 21(5):3425-32. PubMed ID: 11848504
    [Abstract] [Full Text] [Related]

  • 30. Effects of dietary folate on the development and progression of mammary tumors in rats.
    Kotsopoulos J, Medline A, Renlund R, Sohn KJ, Martin R, Hwang SW, Lu S, Archer MC, Kim YI.
    Carcinogenesis; 2005 Sep 01; 26(9):1603-12. PubMed ID: 15888495
    [Abstract] [Full Text] [Related]

  • 31. [Anti-mutagenicity activity of dehydroepiandrosterone].
    Yang S, Fu Z, Wang F, Cao Y, Han R.
    Zhonghua Zhong Liu Za Zhi; 2002 Mar 01; 24(2):137-40. PubMed ID: 12015034
    [Abstract] [Full Text] [Related]

  • 32. NTP Toxicology and Carcinogenesis Studies of Pentachloroanisole (CAS No. 1825-21-4) in F344 Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Apr 01; 414():1-284. PubMed ID: 12616284
    [Abstract] [Full Text] [Related]

  • 33. NTP Studies of Magnetic Field Promotion (DMBA Initiation) in Female Sprague-Dawley Rats (Whole-body Exposure/Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1999 Aug 01; 489():1-148. PubMed ID: 12563342
    [Abstract] [Full Text] [Related]

  • 34. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM, Christov K.
    Anticancer Res; 2003 Aug 01; 23(4):3207-13. PubMed ID: 12931682
    [Abstract] [Full Text] [Related]

  • 35. Effects of retinyl acetate and melatonin on N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats. A preliminary report.
    Bojková B, Kubatka P, Môciková K, Mníchová M, Ahlersová E, Ahlers I.
    Folia Biol (Praha); 2000 Aug 01; 46(2):73-6. PubMed ID: 10813094
    [Abstract] [Full Text] [Related]

  • 36. Retinoids as chemopreventive agents for breast cancer.
    Moon RC, Mehta RG, Detrisac CJ.
    Cancer Detect Prev; 1992 Aug 01; 16(1):73-9. PubMed ID: 1551141
    [Abstract] [Full Text] [Related]

  • 37. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD, Allred KF, Ju YH, Clausen LM, Doerge DR, Schantz SL, Korol DL, Wallig MA, Helferich WG.
    Carcinogenesis; 2004 Feb 01; 25(2):211-8. PubMed ID: 14578162
    [Abstract] [Full Text] [Related]

  • 38. Retinyl ethers as cancer chemopreventive agents. Suppression of mammary cancer.
    Shealy YF, Frye JL, Riordan JM, Hill DL, McPhillips M, Wille JJ, Sani BP, Kalin JR, Eto I, Grubbs CJ.
    Anticancer Drug Des; 1997 Jan 01; 12(1):15-33. PubMed ID: 9051111
    [Abstract] [Full Text] [Related]

  • 39. Body zinc distribution profile during N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats at various levels of dietary zinc intake.
    Woo W, Xu Z.
    Biol Trace Elem Res; 2002 Jan 01; 87(1-3):157-69. PubMed ID: 12117225
    [Abstract] [Full Text] [Related]

  • 40. Chemoprevention of MNU-induced mammary tumorigenesis by hormone response modifiers: toremifene, RU 16117, tamoxifen, aminoglutethimide and progesterone.
    Moon RC, Steele VE, Kelloff GJ, Thomas CF, Detrisac CJ, Mehta RG, Lubet RA.
    Anticancer Res; 1994 Jan 01; 14(3A):889-93. PubMed ID: 8074489
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.